Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanomaS Danson, P Lorigan, A Arance, et al.
International Journal of Cancer|January 11, 2000
O(6)-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenograftsM R Middleton, J Kelly, N Thatcher, et al.
Communications Medicine|May 14, 2026
Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment predictionS Conroy, H Gagg, L A Quayle, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|June 5, 2014
Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complicationsJ M Findlay, R C Tilson, A Harikrishnan, et al.
Cancer Chemotherapy and Pharmacology|December 30, 2009
A phase I trial of lomeguatrib and irinotecan in metastatic colorectal cancerA Sabharwal, P G Corrie, R S Midgley, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 20, 2014
The effect of formalizing enhanced recovery after esophagectomy with a protocolJ M Findlay, E Tustian, J Millo, et al.
British Journal of Cancer|May 14, 2008
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancerO A Khan, M Ranson, M Michael, et al.
Pageof 6